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ABSTRACT Human papillomaviruses recruit a host of DNA damage response fac-
tors to their viral genome to facilitate homologous recombination replication in
association with the viral replication factors E1 and E2. We previously demon-
strated that SIRT1 deacetylation of WRN promotes recruitment of WRN to E1-E2
replicating DNA and that WRN regulates both the levels and fidelity of E1-E2
replication. The deacetylation of WRN by SIRT1 results in an active protein able
to complex with replicating DNA, but a protein that is less stable. Here, we dem-
onstrate an inverse correlation between SIRT1 and WRN in CIN cervical lesions
compared to normal control tissue, supporting our model of SIRT1 deacetylation
destabilizing WRN protein. We CRISPR/Cas9 edited N/Tert-1 and N/Tert-1HPV16
cells to knock out WRN protein expression and subjected the cells to organo-
typic raft cultures. In N/Tert-1 cells without WRN expression, there was enhanced
basal cell proliferation, DNA damage, and thickening of the differentiated epithe-
lium. In N/Tert-1HPV16 cells, there was enhanced basal cell proliferation, in-
creased DNA damage throughout the epithelium, and increased viral DNA repli-
cation. Overall, the results demonstrate that the expression of WRN is required
to control the proliferation of N/Tert-1 cells and controls the HPV16 life cycle in
these cells. This complements our previous data demonstrating that WRN con-
trols the levels and fidelity of HPV16 E1-E2 DNA replication. The results describe
a new role for WRN, a tumor suppressor, in controlling keratinocyte differentia-
tion and the HPV16 life cycle.
IMPORTANCE HPV16 is the major human viral carcinogen, responsible for around
3 to 4% of all cancers worldwide. Our understanding of how the viral replication
machinery interacts with host factors to control/activate the DNA damage re-
sponse to promote the viral life cycle remains incomplete. Recently, we demon-
strated a SIRT1-WRN axis that controls HPV16 replication, and here we demon-
strate that this axis persists in clinical cervical lesions induced by HPV16. Here,
we describe the effects of WRN depletion on cellular differentiation with or with-
out HPV16; WRN depletion results in enhanced proliferation and DNA damage ir-
respective of HPV16 status. Also, WRN is a restriction factor for the viral life cycle
since replication is disrupted in the absence of WRN. Future studies will focus on
enhancing our understanding of how WRN regulates viral replication. Our goal is
to ultimately identify cellular factors essential for HPV16 replication that can be
targeted for therapeutic gain.
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Human papillomaviruses (HPV) are causative agents in around 5% of all cancers,including over 90% of cervical and 70 to 80% of oropharyngeal (1). After infection
of basal epithelial cells, cellular factors binding to the Long Control Region (LCR) induce
viral transcript expression (2). This transcript is then processed and translated to
produce the viral proteins. The major viral oncogenes E6 and E7 target, among other
host proteins, p53 and pRb function, respectively, resulting in enhanced proliferation of
the infected cell (3). Two viral proteins are required for replication of the viral genome:
E1 and E2 (4). E2 is a DNA binding protein that forms homodimers and binds to 12-bp
palindromic sequences in the LCR surrounding the A/T-rich origin of viral replication (5).
Via a protein-protein interaction, E2 recruits E1 to the origin of replication, and E1 then
forms a dihexameric complex and interacts with host DNA polymerases to regulate
replication of the viral genome (6). Following initiation of replication, the viral genome
establishes in the infected cell at 20 to 50 copies per cell. The proliferating cell then
migrates through the epithelium, maintaining 20 to 50 genome copies per cell. In the
upper layers of the epithelium, the viral genome undergoes amplification to around
1,000 copies per cell and, at this stage, the structural L1 and L2 proteins are expressed.
L1 and L2 then encapsulate the viral genome, forming infectious particles that egress
from the upper layers of the epithelium (7–9).
During the initial establishment phase of viral replication, there is torsional stress on
the 8-kbp genome as it produces the 20 to 50 copies per cell that establish infection
(10). This creates the formation of damaged DNA structures on the replicating genome
and activation of the DNA damage response (DDR). HPV proteins E7 and E1 can also
directly activate the DDR when overexpressed in epithelial cells (11–20). The HPV cells
proliferate with an active DDR, an unusual outcome as activation of the DDR by external
agents ordinarily promotes a cell cycle arrest in order to repair host DNA damage
mediated by the external agent (21). This active DDR in the HPV-infected cells is
required for the amplification stage of the viral life cycle; disruption of the ATM and
ATR DDR kinases blocks the amplification stage (21). The replicating viral DNA recruits
a number of DDR proteins to promote replication of the viral genome, a process
proposed to occur via homologous recombination (HR). The MRN (MRE11-RAD50-NBS1)
complex is among the first proteins recruited to damaged DNA, and all three compo-
nents of MRN are recruited to the viral genome (22, 23). Additional factors involved in
HR are recruited to the viral genome, including RAD51 and BRCA1 (24). Many of these
DDR proteins are essential for completion of the HPV life cycle.
Our lab has focused on identifying cellular proteins that interact with the viral
replication factors E1 and E2 as a means of enhancing our incomplete understanding
of host-pathogen interactions that are essential for HPV life cycles, using HPV16 as a
model. HPV16 is responsible for around 50% of HPV-positive cervical cancers and 80 to
90% of HPV-positive oropharyngeal cancers. We have identified several proteins as
being involved in E1-E2 DNA replication, including TopBP1, SIRT1, and WRN, all proteins
that have key roles in the DNA damage response, HR, and DNA replication (25–30). Our
recent work on WRN demonstrated that deacetylation of this protein by SIRT1 (a
protein that also deacetylates TopBP1) promotes binding of WRN to HPV16 origin
containing plasmid DNA being replicated by E1-E2 (25). CRISPR/Cas9 removal of SIRT1
expression results in hyperacetylation and stabilization of WRN. However, this acety-
lated WRN is unable to efficiently complex with E1-E2 replicating DNA, as determined
by chromatin immunoprecipitation. WRN has 3= to 5= exonuclease and helicase activity
and is involved in multiple DNA damage and repair processes, including nonhomolo-
gous end joining (31–34). However, it is also involved in HR and replication, and since
this is the process used by E1-E2 to replicate the viral genome, the role of WRN in viral
replication is to promote HR (32, 35–42). In the absence of SIRT1, E1-E2 replication has
a reduced fidelity, and one reason for this could be the lack of WRN recruitment to the
replicating DNA (26). CRISPR/Cas9 editing of WRN from C33a cells resulted in a similar
phenotype to that of SIRT1 deletion: increased DNA replication that has a reduced
fidelity (25). Therefore, a SIRT1-WRN axis controls recruitment of WRN to E1-E2 repli-
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cating DNA, and a lack of SIRT1 or WRN results in mutagenic HPV16 E1-E2 DNA
replication (25).
The E1-E2 replication assays were carried out in C33a cells, an HPV-negative cervical
cancer cell line routinely used for viral replication and transcription assays. In this
report, we expand our investigation of WRN in the HPV16 life cycle. We demonstrate
that in CIN1, -2, and -3 lesions there is an increasing tendency for elevated SIRT1
expression and reduced WRN expression. This inverse correlation of expression of
these proteins reflects what we observe in our C33a studies where SIRT1 activity
deacetylates and destabilizes WRN, although the deacetylated WRN is active in
interacting with the E1-E2 replicating DNA and promoting high-fidelity DNA repli-
cation (25). Others have also demonstrated regulation of WRN function by SIRT1
deacetylation (43–45) SIRT1 is essential for the HPV31 life cycle in cervical keratin-
ocytes, demonstrated by using shRNA to eliminate SIRT1 expression (30). We
therefore moved on to investigate the role of WRN during the HPV16 life cycle. We
have established a model system in our lab for the HPV16 life cycle using N/Tert-1
cells (46–48). In this system, N/Tert-1HPV16 cells are transcriptionally repro-
grammed in a manner expected for HPV16. In addition, these cells support a variety
of life cycle markers, including increased proliferation, enhanced incorporation of
BrdU, enhanced DNA damage, E1^E4 expression, and amplification of the viral
genome in the upper layers of the differentiated epithelium, as demonstrated by
fluorescent in situ hybridization (FISH). Having the parental N/Tert-1 cells allows
comparison of interaction of genes with the HPV16 life cycle. To exploit this system,
we used CRISPR/Cas9 editing to reduce WRN protein expression in N/Tert-1 and
N/Tert-1HPV16 cells. The parental N/Tert-1 cells demonstrated an enhanced
proliferative phenotype in the absence of WRN, with increased DNA damage. In
N/Tert-1HPV16 cells lacking WRN there was an increased basal cell layer prolif-
eration phenotype with enhanced DNA damage throughout the epithelium. There
was also enhanced numbers of cells supporting viral genome amplification and an
overall increase in viral DNA replication as determined by reverse transcription-
quantitative PCR (RT-qPCR). Importantly, there was an increase in HPV16 replication
in suprabasal cells in the WRN depleted N/Tert-1 cells, demonstrating a key role for
WRN in controlling HPV16 replication throughout the epithelium. Overall, the
results demonstrate that WRN expression is required for normal epithelial cell
differentiation and also for controlling the HPV16 life cycle in differentiating
keratinocytes. The results demonstrate that WRN is a restriction factor for HPV16,
controlling the DNA damage induced by the virus and the overall replication levels
of the virus throughout the epithelium.
RESULTS
Inverse correlation between SIRT1 and WRN expression in HPV16-positive
cervical lesions. Our recent work demonstrated that deacetylation of WRN by SIRT1
promotes binding of WRN to E1-E2 replicating DNA (25). Removal of SIRT1 resulted in
hyperacetylation and stabilization of WRN. In addition, removal of WRN expression from
C33a cells by CRISPR/Cas9 resulted in a similar phenotype to that of SIRT1 deletion;
increased DNA replication that has a reduced fidelity (25). Therefore, a SIRT1 controls
the recruitment of WRN to E1-E2 replicating DNA, and depletion of SIRT1 or WRN results
in mutagenic HPV16 E1-E2 DNA replication. These data suggest that manipulation of
the SIRT1-WRN axis by HPV may promote cervical disease progression.
To investigate this, we utilized cervical liquid-based cytology samples from a cohort
of HPV16 patients representing the progression of cervical disease (CIN1 to CIN3)
and compared this to HPV- normal cervical tissue for SIRT1/WRN protein and mRNA
expression (49, 50). Figure 1A demonstrates that decreased WRN mRNA expression
negatively correlated with cervical disease progression through CIN1 to CIN3; in
contrast, SIRT1 expression positively correlated with cervical disease progression. In
agreement with these data, WRN protein expression negatively correlated with cervical
disease expression, whereas SIRT1 protein expression positively correlated with cervical
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disease progression (Fig. 1C; quantification of a larger subset in Fig. 1C). Our previous
data demonstrated that depletion of SIRT1 stabilized WRN protein by promoting its
acetylation (25); when we compared the protein expression of SIRT1 and WRN in
matched samples, we observed that WRN expression negatively corelated with SIRT1
expression during cervical disease progression (Fig. 1D; CIN1, r  0.6843, P  0.005;
CIN2, r  0.6662, P  0.007; CIN3, r  0.5200, P  0.047). Importantly, this was not
observed at the mRNA level (Fig. 1E). Therefore, although there is an overall trend for
WRN mRNA downregulation and SIRT1 mRNA upregulation in the CIN samples (Fig. 1A),
this was not directly correlative in the individual samples. Together, these data support
our previous studies demonstrating that SIRT1 modulates WRN expression in a post-
translational manner (i.e., by deacetylation) and suggest that the SIRT1-WRN axis may
contribute to cervical disease progression.
Generation of WRN depleted N/Tert-1 and N/Tert-1HPV16 cells using CRISPR/
Cas9. To determine the role of WRN in the HPV16 life cycle, N/Tert-1 and N/Tert-1
HPV16 WRN knockout cells were generated using CRISPR/Cas9 targeting (Fig. 2A).
Figure 2A demonstrates that the CRISPR/Cas9 targeting of WRN reduced the expression
of WRN protein in a heterogeneous cellular pool. To further confirm WRN depletion, we
used an MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] assay
using a WRN helicase inhibitor, the rationale being that the WRN depleted cells should
FIG 1 WRN and SIRT1 expression are differentially regulated in cervical disease and negatively correlated at the protein level. (A) Scatter dot plot of RT-qPCR
analysisWRN and SIRT1mRNA expression from a panel of cervical cytology samples representing CIN legions of increasing grade. Five samples from each clinical
grade (neg, CIN1 to -3) were analyzed in batches containing one from each grade. Samples from CIN1 to -3 were then calculated as the fold change compared
to the negative sample, which was set as 1. Expression was normalized against U6 mRNA expression. (B) Representative Western blots from cytology samples
of CIN lesions of increasing grade analyzed for WRN and SIRT1 expression. GAPDH served as a loading control. (C) Scatter dot plot of densitometry analysis of
a panel of cytology samples for WRN and SIRT1 expression. Fifteen samples from each clinical grade (neg, CIN1 to -3) were analyzed by Western blotting, and
densitometry analysis was performed using ImageJ. (D) Scatter dot plot analysis of WRN and SIRT1 expression in matched cervical cytology samples in CIN1-3.
(E) Scatter dot plot analysis ofWRN and SIRT1mRNA expression in matched cervical cytology samples in CIN1-3. Correlation between WRN and SIRT1 expression
was calculated using Pearson correlation coefficient (r) analysis. Error bars represent the means  the standard deviations. ns, not significant; *, P  0.05; *, P 
0.01; ***, P  0.001 (Student t test).
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have enhanced resistance to the drug as the cells will be reprogrammed to grow in the
absence of WRN. Figure 2B, left panel, demonstrates that this is the case for the N/Tert-1
cells; the WRN-depleted cells (N/Tert-1-WRN) have a statistically significantly enhanced
resistance to NSC19630. In N/Tert-1HPV16 cells (right panel), there was little differ-
ence between the N/Tert-1HPV16 and N/Tert-1HPV16-WRN in their response to
NSC19630. This suggests that the WRN present in the N/Tert-1HPV16 cells is atten-
uated in function; the 50% inhibitory concentration (IC50) for N/Tert-1HPV16 and
N/Tert-1HPV16-WRN is similar to N/Tert-1-WRN. This is similar to other DNA damage
response proteins that are manipulated by E6 and E7 to abrogate their wild-type
function and recruit them to the viral DNA to promote viral DNA replication (51). This
disruption of the wild-type function of these DNA damage response proteins also
blocks their ability to signal to the host DNA that there is an active DDR, which would
ordinarily promote a cell cycle arrest. The N/Tert-1HPV16 cells have an active DDR
turned on (48).
WRN depletion enhances the proliferation of N/Tert-1 cells. In order to investi-
gate the role of WRN in regulation of cell proliferation and differentiation of epithelial
cells and whether WRN depletion altered the HPV16 life cycle during this process,
N//Tert-1, N/Tert-1-WRN, N/Tert-1HPV16, and N/Tert-1HPV16-WRN were subjected
to organotypic raft culture experiments. Figure 3A presents representative images from
hematoxylin and eosin (H&E) staining of the cultures and are representative of two
independent raft experiments for each cell line. The presence of HPV16 enhances the
thickness of the N/Tert-1 cells as expected (compare N/Tert-1 with N/Tert-1HPV16;
independent rafts were fully scanned using a Vectra Polaris machine that calculated
their overall thickness [“height”]). Furthermore, the depletion of WRN had a marked
effect on the raft culture, increasing the thickness of the raft substantially (Fig. 3B). This
demonstrated the significance of the enhanced thickening of the epithelium following
WRN depletion or expression of HPV16.
One way to investigate the effects of WRN depletion on proliferation is to measure
bromodeoxyuridine (BrdU) incorporation in the raft cultures; cultures were labeled with
BrdU for 16 h prior to harvesting. Staining with a BrdU antibody was then carried out
(Fig. 3C), and the results were quantitated (Fig. 3D); the images are representative, and
the quantitation is an average from the independent raft experiments. N/Tert-1-WRN
cells have an enhanced basal layer proliferative capacity since they have incorporated
more BrdU than the N/Tert-1 cells. Similarly, HPV16 enhances BrdU incorporation in the
N/Tert-1 cells, as we previously demonstrated (47). While not clearly evident on the
images, the lack of WRN also increased BrdU incorporation into the N/Tert-1HPV16
cells. Although difficult to quantitate, there was an increase of suprabasal cells staining
positive for BrdU in the N/Tert-1-WRN, N/Tert-1HPV16, and N/Tert-1HPV16-WRN
compared to N/Tert-1.
FIG 2 Depletion of WRN from N/Tert-1 and N/Tert-1HPV16 cells using CRISPR/Cas9. (A) A plasmid targeting WRN using CRISPR/Cas9 was transfected into
N/Tert-1 and N/Tert-1HPV16 cells, and pooled cell lines were selected following puromycin treatment. We have used this targeting plasmid previously (25).
Western blotting revealed reduced WRN expression in the targeted cell lines (compare lanes 2 and 4 to lanes 1 and 3). (B) The indicated cell lines were treated
with the WRN helicase inhibitor NSC19630, and cell survival was estimated using an MTT assay. With N/Tert-1 and N/Tert-1-WRN cells, there was a statistically
significant difference in the response to the drug from the 1 M concentration forward (P  0.05). For the N/Tert-1HPV16 pair, there was no statistically
significant difference between N/Tert-1HPV16 and N/Tert-1HPV16-WRN. This was determined by using a Student t test.
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FIG 3 Knockdown of WRN increases proliferation during differentiation. (A) WRN CRISPR and control cell
lines (Fig. 2) were differentiated for 13 days by organotypic raft culture. Fixed 4-m sections were
subjected to H&E staining, and representative samples are shown. (B) Two H&E-stained sections from two
individual rafts were imaged, and measurements were taken at 100-m intervals across the length of
each section. Compared to parental lines, N/Tert-1 WRN CRISPR lines were hyperproliferative. HPV16
increases proliferation that was not enhanced significantly following WRN removal. (C) The nucleoside
analog BrdU was included in media for the final 16 h of organotypic raft culture. Fixed sections were
stained for BrdU incorporation. (D) The number of BrdU-positive cells was counted using a Vectra Polaris
(Continued on next page)
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It is possible that enhanced BrdU labeling could be related to an increase in DNA
damage being repaired in the organotypic raft cultures. Therefore, we investigated
the expression of cyclin E in the tissues as an additional marker of cell proliferation.
Figure 3D presents a representative image from the staining. Figure 3E summarizes
the quantitation of the staining on duplicate slides from two independent rafts. The
deletion of WRN in N/Tert-1 cells results in a significant increased cyclin E staining in the
basal layer of the epithelium. The presence of HPV16 also increases cyclin E staining in
the basal layer of the epithelium, compared to N/Tert-1 parental cells. In the N/Tert-
1HPV16 cells with WRN depleted there was no significant increase in cyclin E staining.
Taken together the BrdU and cyclin E results demonstrate that the removal of
WRN from N/Tert-1 cells results in increased proliferation in the basal compartment. In
N/Tert-1HPV16 cells there was no significant increase in cyclin E staining in the
absence of WRN even though there was a significant increase in BrdU incorporation in
the basal layer. The increase in BrdU incorporation may be related to the increased DNA
damage detected in N/Tert-1HPV16 cells when WRN is depleted (see Fig. 5).
We next investigated differentiation markers in the cells to determine whether WRN
depletion was having an effect on this process by staining for Keratin-10 and Involucrin
(Fig. 4). In the N/Tert-1-WRN and N/Tert-1HPV16 cells there is a slight change in
Involucrin staining as basal and immediately suprabasal cells have a delayed expression
compared to N/Tert-1. This indicates a short delay in differentiation but that the overall
differentiation process is occurring in the N/Tert-1-WRN and N/Tert-1HPV16 cells.
Therefore, the enhanced proliferation is not due to a failure of the cells to differentiate.
WRN depletion alters the HPV16 life cycle in N/Tert-1 cells. We next looked at a
variety of life cycle markers in the rafts to determine whether the depletion of WRN
interferes with the HPV16 life cycle in N/Tert-1 cells. H2AX staining has been used as
a surrogate marker for HPV16 replication during the viral life cycle, particularly during
the amplification stage of the life cycle in the upper layers of the epithelium (21). We
FIG 3 Legend (Continued)
imaging system. Whole stained sections were scanned computationally, and the intensity was calculated
compared to a negative background control (secondary antibody only) and a positive localization control
(DAPI). The same imaging parameters were used for each slide. Three sections from two individual rafts
were subjected to analysis. BrdU incorporation in basal cells is enhanced in both N/Tert-1 and N/Tert-
1HPV16 cells in the absence of WRN. Error bars indicate the standard errors of the mean (*, P  0.05).
(E) The indicated rafts were stained with cyclin E. (F) The number of cyclin E-positive cells was counted
using a Vectra Polaris imaging system. Whole stained sections were scanned computationally, and the
intensity calculated was compared to a negative background control (secondary antibody only) and a
positive localization control (DAPI). The same imaging parameters were used for each slide. Three
sections from two individual rafts were subjected to analysis. Error bars indicate the standard errors of
the mean (*, P  0.05).
FIG 4 Knockdown of WRN has no affect upon differentiation of N/Tert-1 cell lines. Sections were stained with the indicated
antibodies. Both proteins are markers of terminal differentiation and are observed in suprabasal cells but absent from basal
cells, as expected during normal organotypic raft culture. DNA was stained with DAPI. The images are representative of
two individual rafts grown per cell line.
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stained our N/Tert-1 panel of cells with H2AX, and Fig. 5A presents representative
images of the results. There was a residual level of H2AX staining in N/tert-1 cells;
however, WRN depletion increases the number of cells that are H2AX positive. This
demonstrates that an increase in DNA damage accompanies the increased proliferation
induced by the removal of WRN (Fig. 3). As expected, the presence of HPV16 induced
increased H2AX staining in the upper layers of the differentiating epithelium where
genome amplification occurs, with weaker but consistent staining in the basal layers of
the epithelium. Depletion of WRN in the N/Tert-1HPV16 cells increases the number of
cells staining positive for H2AX; in particular, there is an increase in basal layer cells
staining positive, with corresponding increase in the intensity of the signal. We quan-
titated the H2AX-positive cells using the Vectra Polaris machine, and Fig. 5B demon-
strates that depletion of WRN or the presence of HPV16 increases the overall H2AX
FIG 5 Knockdown of WRN increases DNA damage. (A) To visualize DNA damage throughout differentiated sections, staining for
H2AX was carried out. Phosphorylation of H2AX at Ser-139 (-H2AX) correlates with sites of DNA damage. Cellular DNA was
stained with DAPI. (B) The number of yH2AX-positive cells was measured using a Vectra Polaris imaging system. Whole stained
sections were scanned computationally, and the intensity was calculated compared to a negative background control (secondary
antibody only) and a positive localization control (DAPI). (C) The number of yH2AX-positive cells was calculated as a fraction of
the number of basal cells, where only the basal yH2AX counts were included in quantification. Three sections from two individual
rafts were subjected to analysis. Error bars indicate the standard error of the means (*, P  0.05).
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staining percentage. Staining of the basal layers demonstrates a large increase in
H2AX staining in the absence of WRN, and this is also observed in the presence of
HPV16 (Fig. 5C). Overall, the results demonstrate that WRN depletion results in elevated
H2AX staining in the absence or presence of HPV16 in N/Tert-1 cells. These results also
demonstrate detectable DNA damage in the N/Tert-1HPV16-WRN basal cells that is
not detected in N/Tert-1HPV16. This correlates with the BrdU incorporation, where
depletion of WRN increases BrdU incorporation in N/Tert-1HPV16 when WRN is
depleted (Fig. 3).
Using fluorescent in situ hybridization (FISH) to detect the HPV16 genome, we
investigated the regulation of the viral genome during differentiation of the N/Tert-1
cells. Figure 6A demonstrates the usual FISH signal detected in the upper layers of the
differentiated epithelium in N/Tert-1HPV16, representative of amplification of the
viral genome. WRN depletion resulted in detection of the viral genome throughout
the differentiating epithelium with a concentration in the upper layers remaining. Using
our Vectra Polaris machine, we quantitated the staining for the number of cells that are
HPV16 positive and the intensity of the staining (Fig. 6B).
We next investigated the expression of E1^E4 staining in the epithelium to deter-
mine whether this late stage marker of the viral life cycle is disrupted following
depletion of WRN. Figure 6C demonstrates that this was not the case, the depletion of
WRN had no significant effect on the expression of E1^E4. The E1^E4 staining is similar
to that observed by others (52). We also extracted protein from rafts, and there was no
significant increase in E1^E4 protein expression on Western blots following WRN
depletion (not shown).
The expression of E1^E4 demonstrates that episomal genomes remain in the
N/Tert-1HPV16-WRN cells. We carried out Southern blots and real-time PCR to
investigate further the status of the viral genomes in the cells. A single cutter on the
viral genome (SphI) generated an 8kbp band in all samples irrespective of monolayer,
raft or WRN status (Fig. 7A). Treatment with HindIII, a noncutter of the viral genome,
resulted in a uniform detection of nicked DNA (Fig. 7B). We did not observe supercoiled
DNA on this blot, perhaps due to the DNA preparation protocol. The uniform nature of
the bands in Fig. 7A and B, combined with the E1^E4 status, demonstrates a large
presence of episomal viral genomes in the presence or absence of WRN. Since Southern
blots are at best semiquantitative, we carried out real-time PCR on the DNA harvested
from the rafts. We monitored for the levels of E6 DNA, and Fig. 7C demonstrates that
there is a small but significant increase in viral genomes following WRN depletion. This
is in agreement with the FISH data (Fig. 6). These results demonstrate that the HPV16
genome remains episomal following WRN depletion and that there is an increase in
viral genome copy number.
DISCUSSION
Our previous work demonstrated that WRN was a substrate for SIRT1, in agreement
with other reports (25, 43, 44). The consequence of SIRT1 depletion by CRISPR/Cas9 was
an enhanced acetylation and stabilization of WRN; however, acetylated WRN is unable
to complex with damaged and E1-E2 replicating DNA, perhaps due to the negative
charge associated with acetylation (25). In the absence of SIRT1, there was a reduction
of HPV16 E1-E2 replication fidelity and a decreased recruitment of WRN to the repli-
cating DNA. The role of WRN in regulation of HR could at least partially account for the
mutagenic replication in the absence of SIRT1. Indeed, following WRN depletion by
CRISPR/Cas9 targeting there was also a reduction in the fidelity of E1-E2 DNA replica-
tion. Our mechanistic studies therefore suggested a SIRT1-WRN axis controlling viral
DNA replication fidelity (25). There is also an important role for SIRT1 during the HPV31
life cycle: the removal of SIRT1 blocked viral genome amplification (30). That study
demonstrated alteration in viral genome histone modifications that could have con-
tributed to the failure to amplify the viral genome during epithelial cell differentiation.
To investigate the SIRT1-WRN axis further, we studied the expression levels of these
proteins in naturally occurring cervical HPV-positive CIN1, -2, and -3 lesions compared
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to normal cervical tissue (Fig. 1). While there is a tendency toward increasing SIRT1
mRNA levels and decreasing WRN mRNA levels as disease progresses, there is a clear
inverse correlation between SIRT1 and WRN protein expression during disease progres-
sion. This was not accounted for by mRNA levels since, with individual lesions, there
was no clear inverse correlation between expression of SIRT1 and WRN mRNA. Overall,
this study suggested that elevated SIRT1 results in decreased WRN acetylation and
stability during HPV16 disease progression. The deacetylated WRN, although reduced in
stability and therefore detectable levels in these lesions, is much more active at
complexing with replicating DNA and promoting HR repair.
To investigate the role of WRN during the viral life cycle, we exploited our N/Tert-1
FIG 6 Depletion of WRN increases the number of cells supporting viral replication in the differentiating epithelium. (A)
N/Tert-1HPV16 and N/Tert-1HPV16 CRISPR WRN cells were differentiated in culture, formalin fixed, paraffin embedded,
sectioned, and then stained for HPV16 genomes using DNA-FISH. Images shown are representative images of HPV-FISH in
differentiated culture. (B) Both the percentage of HPV16-positive cells and the intensity of fluorescence was quantified using the
Vectra Polaris imaging system. The intensity of fluorescence was calculated compared to a negative background control (N/Tert-1),
and the same imaging parameters were used for each slide. Three sections from two individual rafts were subjected to analysis,
and error bars indicate the standard errors of the mean (*, P  0.05). (C) Sections were stained with HPV16 E1^E4 to investigate
whether a productive viral life was occurring. The E1^E4 spliced variant is expressed during the late stages and in upper layers
of epithelium. Here, we observe that E1^E4 expression occurs regardless of WRN depletion.
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model. N/Tert-1 are hTERT immortalized human foreskin keratinocytes, and we gener-
ated cell lines containing HPV16, N/Tert-1HPV16 (46–48, 53). This system has the
direct advantage of being able to manipulate control cells (N/Tert-1) without the viral
genome but with the same genetic lesions as the N/Tert-1HPV16 cells. Without this
comparison, it would be more difficult to determine whether the changes observed in
the presence of HPV16 with the genetic lesion is due to the presence of the virus or due
to the effect of the lesion on the epithelium. CRISPR/Cas9 targeting generated N/Tert1-
WRN and N/Tert-1HPV16-WRN; the plasmid used to target WRN has been described
previously (25) (Fig. 2). We tested the effect of a WRN helicase inhibitor, NSC19630, on
the viability of wild-type and WRN-depleted N/Tert-1 and N/Tert-1HPV16 and ob-
served that the N/Tert-1-WRN cells were more resistant to this drug than the control
N/Tert-1, as would be expected. This drug obviously has toxicity and off-target effects
as the N/Tert-1-WRN cells were still susceptible to growth attenuation when treated
with NSC 19630. Interestingly, in N/Tert-1HPV16 the absence of WRN made no
difference to their growth in the presence of NSC19630. This suggests that, in N/Tert-
1HPV16 cells, the WRN that is present is not functioning correctly. Indeed, the IC50
values for N/Tert-1HPV16 and N/Tert-1HPV16-WRN are both similar to that for
N/Tert-1-WRN. This suggests that, in HPV16-positive cells, WRN function on the host
genome is attenuated and that it is recruited to the viral genome to assist with viral
replication. This is similar to other DNA repair factors; E6 and E7 manipulate these
factors so that they do not interact correctly with the host genome (51). Using this
mechanism, the virus would allow the presence of an active DDR to promote the viral
life cycle but prevent the host cell detecting this damage by subverting the ability of
host factors to signal the damage to the host replication machinery. This would allow
proliferation with an active DDR in HPV16-positive cells. We are currently investigating
the mechanism that HPV16 uses to subvert the normal function of WRN in HPV16-
positive cells.
FIG 7 WRN depletion does not dramatically alter the status of the HPV16 genome. (A and B) DNA was extracted from monolayer and
raft cultures of parental and CRISPR WRN cells. The DNA was then digested with a single cutter (SphI) (A) or a noncutter (HindIII) (B)
of the HPV16 genome and subjected to Southern blot analysis with an HPV16 genome probe. (C) The same DNA was subjected to
PCR analysis using E6 primers. To calculate HPV amplification, E6 ΔCT values were first calculated relative to mitochondrial
housekeeping gene and ΔΔCT relative to the parental cells line (N/Tert-1HPV16). Error bars indicate the standard errors of the mean
of two experimental repeats (*, P  0.05).
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To determine the effect of WRN depletion on the viral life cycle, we subjected the
cell lines to organotypic raft culture, followed by investigation of markers of the viral life
cycle. Figure 3 demonstrates that, in the absence of WRN, there is a thickening of the
N/Tert-1 differentiating tissue to a level similar to rafts containing HPV16. It is possible
that there is synergism between TERT immortalization and WRN depletion that con-
tributes to the enhanced proliferation detected. Future studies will clarify this by
investigating the effect of WRN knockdown on the proliferation and differentiation of
primary human foreskin keratinocytes. There was no further increase in epithelial
proliferation in N/Tert-1HPV16 cells in the absence of WRN. Werner syndrome pa-
tients suffer from progeria but are also predisposed to certain cancers; therefore, WRN
is a tumor suppressor protein (31, 54, 55). The thickening of the N/Tert-1 epithelium
in the absence of WRN is a proliferative signal, a hallmark of the absence of a tumor
suppressor. To investigate enhanced proliferation in the absence of WRN, we labeled
our cultures with BrdU 16 h before harvesting the rafts, allowing us to stain for BrdU,
and also with cyclin E. Figure 3 demonstrates that the removal of WRN enhances BrdU
incorporation and cyclin E staining in N/Tert-1. In N/Tert-1HPV16 cells, there was an
increase in BrdU incorporation in the basal layer in the absence of WRN but no
significant increase in cyclin E staining. The increase in BrdU labeling is likely related to
increased DNA damage and viral genome replication in the basal layers of the epithe-
lium in the absence of WRN (Fig. 5 and 6). The increase in cell proliferation in N/Tert-1
cells was not due to an obvious attenuation of cell differentiation, since expression of
the differentiation markers Involucrin and Keratin-10 was not altered in the absence of
WRN (Fig. 4).
A hallmark of HPV16 infection is activation of the DDR, detected in differentiated
epithelium; expression of H2AX can be used to detect the induced damage (21).
Figure 5 demonstrates that there is an increase in H2AX signal in N/Tert-1 and
N/Tert-1HPV16 following WRN depletion, demonstrating that the increased prolifer-
ation induced by WRN depletion is accompanied by elevated DNA damage. Such a
phenotype would promote cell transformation, perhaps an expected phenotype fol-
lowing removal of expression of a tumor suppressor protein. In N/Tert-1HPV16 cells
there is detectable DNA damage in the basal layers of the epithelium in the absence of
WRN.
Finally, we moved on to investigate whether depletion of WRN influences the
levels and status of the viral genome in N/Tert-1HPV16 cells (Fig. 6 and 7). Using
FISH, we demonstrated an increase in the number of HPV16-positive cells with
accompanying increase in fluorescent intensity (Fig. 6A and B). A clear phenotype
of WRN depletion was also an increase in the number of FISH signals observed in
the basal and middle layers of the differentiating epithelium. In Fig. 6A and
N/Tert-1HPV16, fluorescent staining is concentrated in the upper layers of the
epithelium where viral genome amplification occurs, as we have reported previ-
ously (48). However, in N/Tert-1HPV16-WRN, there are a significant number of
fluorescent cells in the basal and middle layers of the epithelium. This is in
agreement with the increased DNA damage detected in the absence of WRN in the
N/Tert-1HPV16 cells (Fig. 5). Another marker of late stages of the HPV16 life cycle
is expression of E1^E4 toward the upper layer of the epithelium, which is not
disrupted by the lack of WRN expression (Fig. 6C). This suggested that the viral DNA
remains episomal in the absence of WRN, and Southern blotting demonstrated this
to be the case, both in monolayer and in the differentiating epithelium (Fig. 7).
While these blots do not demonstrate the lack of integration (which would be a
random event in a pool and therefore would not show up as an individual
event/band on a Southern blot) in the absence of WRN, they do demonstrate that
there remains a significant level of episomal viral genomes. Southern blots are
semiquantitative, but real-time qPCR demonstrated an increase in viral genomes in
the absence of WRN, agreeing with the FISH data from Fig. 6.
Overall, the results presented here demonstrate that WRN controls the proliferation
of differentiating epithelium; the absence of WRN elevates proliferation and DNA
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damage irrespective of HPV16 status. In the presence of HPV16, the absence of WRN
increases DNA damage and detectable viral genome replication in basal cells. There-
fore, there is a clear phenotype detected in N/Tert-1HPV16-WRN: an improper am-
plification of the viral genome in the basal and middle layers of the differentiating
epithelium resulting in increased levels of viral DNA. Therefore, WRN functions as a
restriction factor for HPV16 as it controls replication during the differentiating epithe-
lium. This is similar to SAMHD1, another DNA replication and repair factor involved in
homologous recombination (56, 57). Recently, we demonstrated that, although
SAMHD1 levels are downregulated by HPV16, full deletion of SAMHD1 using CRISPR/
Cas9 results in an increased amplification of the viral genome during differentiation
(47). Therefore, there is a delicate interaction between HPV16 and WRN/SAMHD1. These
proteins must be downregulated to promote viral replication but are required for
optimal replication, and their depletion results in enhanced amplification of the viral
genome. Whether this amplification is of high fidelity remains to be determined;
depletion of SIRT1 and WRN results in low-fidelity replication in our HPV16 E1-E2 C33a
cell model (25, 26). Both SAMHD1 and WRN can regulate the function of MRE11, a
component of the MRN complex (MRE11, RAD50, and NBS1) (56–58). MRN function is
required for amplification of HPV31 during epithelial differentiation and therefore has
an effect opposite to that of WRN and SAMHD1, where depletion boosts replication
(22). We are currently investigating whether the WRN and SAMHD1 phenotypes are
mediated via disrupted MRE11 activity.
The SIRT1-WRN axis is crucial for the viral life cycle that controls the levels of viral
DNA replication. Future studies will concentrate on investigating the role of WRN and
partner proteins in the viral life cycle, with the ultimate goal of being able to block viral
replication and/or kill the infected cell.
MATERIALS AND METHODS
Cell line, plasmids, and reagents. N/Tert-1 and N/Tert-1HPV16 cells were grown and maintained
in K-SFM media containing 1% (vol/vol) penicillin-streptomycin mixture and 4 g/ml hygromycin B at
37°C in a 5% CO2 incubator (25). For WRN knockout CRISPR, WRN double-nickase plasmid (sc-401860-NIC)
was purchased from Santa Cruz. N/Tert-1 and N/Tert-1HPV16 WRN–/– pools were generated as
described for the SIRT1 knockout cells (26).
MTT cell proliferation assay. MTT kit (ATCC 30-1010 K) was purchased from the American Type
Culture Collection (ATCC) and was used for the cell proliferation assay. Briefly, the cells were plated in a
96-well tissue culture plate and treated with WRN helicase inhibitor (NSC19630) for a specified time
period. After washing, MTT reagent was added for the formation of the purple crystals, which were later
dissolved using a detergent solution. The absorbance was then measured at 570 nm, and the data are
presented as percentages of the control.
Cervical cytology samples. Cervical cytology samples were obtained from the Scottish HPV
Archive (https://www.ed.ac.uk/pathology/research/scottish-hpv-archive), a biobank of over 20,000
samples designed to facilitate HPV associated research. The East of Scotland Research Ethics Service has
given generic approval to the Scottish HPV Archive as a Research Tissue Bank (REC Ref 11/AL/0174) for
HPV-related research on anonymized archive samples. Samples are available for the present project
though application to the Archive Steering Committee (HPV Archive Application reference no. 0034). RNA
and protein were extracted from the samples using TRIzol and analyzed as previously described (49, 50).
Quantitative reverse transcriptase real-time PCR on cervical cytology RNA samples. Total RNA
was extracted using the E.Z.N.A. Total RNA kit I (Omega Bio-Tek) according to the manufacture’s protocol.
A 1-g portion of total RNA was DNase treated according to the RQ1 RNase-Free DNase protocol
(Promega) and then reverse transcribed with a mixture of random primers and oligo(dT) primers using
the qScript cDNA SuperMix (Quanta Biosciences) according to instructions. RT-qPCR was performed using
the QuantiFast SYBR green PCR kit (Qiagen). The PCR was conducted on a Corbett Rotor-Gene 6000
(Qiagen) as follows: initial activation step for 10 min at 95°C and a three-step cycle of denaturation (10 s
at 95°C), annealing (15 s at 60°C), and extension (20 s at 72°C), which was repeated 40 times and
concluded by melting curve analysis. The following primers were used: WRN Forward, 5=-GCATGTGTTC
GGAAGAGTGTTT-3=; WRN Reverse, 5=-TGACATGGAAGAAACGTGGAA-3=; SIRT1 Forward, 5=-TGCTGGCCTA
ATAGAGTGGCA-3=; and SIRT1 Reverse, 5=-CTCAGCGCCATGGAAAATGT-3=. mRNA expression was normal-
ized against U6 expression using the following primers: U6 Forward, 5=-CTCGCTTCGGCAGCACA-3=; and
U6 Reverse, 5=-AACGCTTCACGCATTTGC-3=. The data obtained was analyzed according to the ΔΔCT
method using the Rotor-Gene 6000 software (59).
Western blotting. Total protein was resolved by SDS-PAGE (10 to 15% Tris-glycine), transferred onto
Hybond nitrocellulose membrane (Amersham Biosciences), and probed with antibodies specific for WRN
(D-6; sc-376182, Santa Cruz Biotechnology [SCBT]), SIRT1 (B-7; sc-74465; SCBT), and GAPDH (G-9;
sc-365062; SCBT). Western blots were visualized by using species-specific horseradish peroxidase-
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conjugated secondary antibodies (Sigma) and enhanced chemiluminescence (Thermo/Pierce). Densitom-
etry analysis was performed using ImageJ analysis software (NIH).
Organotypic raft culture. N/Tert-1 and N/Tert-1HPV16 cells were differentiated via organotypic
raft culture as described previously (46–48). Briefly, cells were seeded onto type 1 collagen matrices
containing J2 3T3 fibroblast feeder cells. Cells were then grown to confluence atop the collagen matrices,
which were then lifted onto wire grids and cultured in cell culture dishes at the air-liquid interface, with
medium replacement on alternate days. At 16 h before fixation, medium was replaced with fresh media
supplemented with 20 M BrdU (final concentration). After 13 days of culture, rafted samples were fixed
with formaldehyde (4% vol/vol) and embedded in paraffin blocks. Multiple 4-m sections were cut from
each sample. For FISH staining, 6-m sections were cut. Sections were stained with H&E and others
prepared for immunofluorescent staining as described previously. Fixing and embedding services in
support of the research project were generated by the VCU Massey Cancer Center Cancer Mouse Model
Shared Resource.
Immunofluorescence. Antibodies used and relevant dilutions are as follows: Involucrin (1/1,000;
Santa Cruz Biotechnology), Keratin-10 (1/2,000; Santa Cruz Biotechnology), BrdU (1/200; Cell Sig-
naling Technology), and phospho-histone H2AX (Ser139; 1/500; Cell Signaling Technology). Cyclin E
antibody (Santa Cruz, HE11) was used at a 1:1,000 dilution. Immune complexes were visualized using
Alexa 488- or Alexa 595-labeled anti-species-specific antibody conjugates (Molecular Probes). Cel-
lular DNA was stained with 4=,6=-diamidino-2-phenylindole (DAPI; Santa Cruz, sc-3598). FISH staining
for HPV16 genomes was performed using digoxigenin-labeled HPV16 genomes, as described
previously (46–48). Microscopy and subsequent quantification performed at the VCU Microscopy
Facility. Image analysis (% staining and staining intensity) was performed using a Vectra Polaris
automated imaging system, whereby whole stained sections were scanned computationally, and the
intensity calculated was compared to a negative background control (secondary antibody only) and
a positive localization control (DAPI). The intensity of immunofluorescence microscopy is a measure
of the photons detected from one emission channel. Intensity was calculated based on the number
of photons at a specific location, thus determining the local concentration of fluorophores (second-
ary antibodies). In this way, this is equivalent to measuring densitometry to estimate protein
concentration from a Western blot. The same imaging parameters were used for each slide and for
each sample, and two sections from three individually grown rafts were scanned to generate
average values. Immunofluorescence was observed by using a LSM 710 laser scanning microscope
and ZEN 2011 software (Carl Zeiss).
Southern blotting. DNA was isolated from monolayer and raft cultures by incubation in HIRT buffer
(0.6% SDS, 10 mM EDTA [pH 7.5 5], M NaCl) and by using phenol-chloroform extraction, as previously
described (48), and then 5 g was digested with either SphI or HindIII to linearize the HPV16 genome or
leave episomes intact, respectively. All digests included DpnI to ensure that all input DNA was digested
and not represented as replicating viral DNA. Digested DNA was separated by electrophoresis of a 0.8%
agarose gel, transferred to a nitrocellulose membrane, and probed with radiolabeled (32P) HPV16
genome. The sample was then visualized by exposure to film for 24 or 72 h.
Quantitative PCR on HPV16 DNA samples. DNA was isolated as described above and subject to
PCR utilizing the SYBR green Master Mix and 7500 Fast real-time PCR system described above. As HIRT
buffer is optimized for the isolation of small DNA, mitochondrial DNA was detected as the internal
control; F, 5=-CAGGAGTAGGAGAGAGGGAGGTAAG-3=; and R, 5=-TACCCATCATAATCGGAGGCTTTGG-3=.
The HPV16 primers were as follows: E6 F, 5=-GAGAACTGCAATGTTTCAGGACC-3=; R, 5=-TGTATAGTTGTTT
GCAGCTCTGTGC-3=; E2 F, 5=-ATGCGGGTGGTCAGGTAATA-3=; and E2 R, 5=-TCGCTGGATAGTCGTCTGTG-3=.
Statistics. The standard error was calculated from three independent experiments, and signifi-
cance was determined using a Student t test. For cervical cytology sample analysis, individual
samples were plotted with error bars representing the standard deviations. Significance was
determined by a two-tailed, unpaired Student t test. Correlation of WRN and SIRT1 expression was
calculated using Pearson correlation coefficient (r) analysis and GraphPad Prism software as previ-
ously described (60).
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